Xinlei Mi
Papers
1
Total Citations
36
H-Index
1
About
Dr. Xinlei Mi is a rising leader in urological surgery, with a focused expertise in minimally invasive treatments for benign prostatic hypertrophy (BPH). His most impactful work, a 2022 comparative outcomes study, rigorously evaluates three major surgical approaches for large-gland BPH: holmium laser enucleation (HoLEP), open simple prostatectomy, and robotic simple prostatectomy. This research, which has garnered 36 citations in just a few years, provides critical, evidence-based guidance for surgeons choosing between these techniques, directly influencing clinical decision-making for patients with enlarged prostates. By systematically analyzing perioperative outcomes, complications, and functional recovery, Dr. Mi’s work helps define the optimal balance between efficacy and invasiveness. His contributions are particularly valuable in an era where robotic and laser technologies are rapidly evolving, offering a clear, data-driven comparison that aids both surgical training and patient counseling. Dr. Mi’s research is essential reading for urologists and residents seeking to understand the modern landscape of BPH surgery, establishing him as a key voice in advancing patient-centered, outcomes-focused urological care.
Research Focus
Key Achievements
Top Papers
- 1